News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
294,783 Results
Type
Article (17516)
Company Profile (282)
Press Release (276985)
Multimedia
Podcasts (52)
Webinars (7)
Section
Business (84538)
Career Advice (160)
Deals (13950)
Drug Delivery (43)
Drug Development (55731)
Employer Resources (31)
FDA (6852)
Job Trends (5857)
News (156687)
Policy (11538)
Tag
Academia (1064)
Accelerated approval (3)
Adcomms (15)
Allergies (54)
Alliances (23201)
ALS (72)
Alzheimer's disease (862)
Antibody-drug conjugate (ADC) (135)
Approvals (6885)
Artificial intelligence (151)
Autoimmune disease (19)
Automation (5)
Bankruptcy (113)
Best Places to Work (5241)
BIOSECURE Act (6)
Biosimilars (47)
Biotechnology (232)
Bladder cancer (68)
Brain cancer (23)
Breast cancer (214)
Cancer (1861)
Cardiovascular disease (130)
Career advice (141)
Career pathing (2)
CAR-T (124)
Cell therapy (350)
Cervical cancer (11)
Clinical research (45519)
Collaboration (592)
Compensation (296)
Complete response letters (15)
COVID-19 (1219)
CRISPR (44)
C-suite (178)
Cystic fibrosis (103)
Data (1718)
Denatured (11)
Depression (34)
Diabetes (149)
Diagnostics (1882)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (92)
Drug pricing (33)
Drug shortages (4)
Duchenne muscular dystrophy (92)
Earnings (32233)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (52200)
Executive appointments (486)
FDA (7668)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (534)
Gene editing (103)
Generative AI (12)
Gene therapy (270)
GLP-1 (394)
Government (1329)
Grass and pollen (2)
Guidances (59)
Healthcare (7472)
Huntington's disease (24)
IgA nephropathy (25)
Immunology and inflammation (104)
Indications (21)
Infectious disease (1301)
Inflammatory bowel disease (120)
Inflation Reduction Act (8)
Influenza (25)
Intellectual property (72)
Interviews (18)
IPO (7661)
IRA (14)
Job creations (945)
Job search strategy (134)
Kidney cancer (7)
Labor market (8)
Layoffs (245)
Leadership (3)
Legal (1627)
Liver cancer (52)
Lung cancer (348)
Lymphoma (114)
Machine learning (5)
Management (7)
Manufacturing (156)
MASH (57)
Medical device (3024)
Medtech (3025)
Mergers & acquisitions (6633)
Metabolic disorders (417)
Multiple sclerosis (54)
NASH (13)
Neurodegenerative disease (74)
Neuropsychiatric disorders (25)
Neuroscience (1289)
NextGen: Class of 2025 (2163)
Non-profit (1171)
Now hiring (22)
Obesity (204)
Opinion (108)
Ovarian cancer (68)
Pain (46)
Pancreatic cancer (66)
Parkinson's disease (121)
Partnered (8)
Patents (146)
Patient recruitment (88)
Peanut (36)
People (26770)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (15577)
Phase II (20924)
Phase III (13938)
Pipeline (950)
Policy (50)
Postmarket research (1087)
Preclinical (6596)
Press Release (30)
Prostate cancer (74)
Psychedelics (35)
Radiopharmaceuticals (219)
Rare diseases (333)
Real estate (1496)
Recruiting (12)
Regulatory (9836)
Reports (16)
Research institute (1124)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (22)
Schizophrenia (62)
Series A (103)
Series B (68)
Service/supplier (1)
Sickle cell disease (43)
Special edition (12)
Spinal muscular atrophy (118)
Sponsored (13)
Startups (2042)
State (1)
Stomach cancer (8)
Supply chain (23)
Tariffs (12)
The Weekly (40)
Vaccines (269)
Venture capitalists (33)
Weight loss (118)
Women's health (16)
Worklife (2)
Date
Today (145)
Last 7 days (560)
Last 30 days (1863)
Last 365 days (20700)
2025 (7268)
2024 (21969)
2023 (24048)
2022 (28923)
2021 (30011)
2020 (25681)
2019 (17981)
2018 (13153)
2017 (15140)
2016 (13346)
2015 (15959)
2014 (11481)
2013 (8344)
2012 (8392)
2011 (8522)
2010 (8314)
Location
Africa (170)
Alabama (42)
Alaska (2)
Arizona (63)
Arkansas (6)
Asia (18971)
Australia (3263)
California (4221)
Canada (1235)
China (396)
Colorado (165)
Connecticut (167)
Delaware (126)
Europe (41162)
Florida (509)
Georgia (124)
Idaho (17)
Illinois (265)
India (11)
Indiana (106)
Iowa (2)
Japan (95)
Kansas (64)
Kentucky (7)
Louisiana (3)
Maine (11)
Maryland (534)
Massachusetts (3271)
Michigan (75)
Minnesota (164)
Mississippi (1)
Missouri (28)
Montana (14)
Nebraska (5)
Nevada (18)
New Hampshire (16)
New Jersey (1126)
New Mexico (15)
New York (1156)
North Carolina (614)
North Dakota (5)
Northern California (1866)
Ohio (117)
Oklahoma (9)
Oregon (21)
Pennsylvania (791)
Puerto Rico (6)
Rhode Island (19)
South America (230)
South Carolina (5)
Southern California (1622)
Tennessee (27)
Texas (517)
United States (14569)
Utah (56)
Virginia (86)
Washington D.C. (33)
Washington State (395)
Wisconsin (20)
294,783 Results for "lung therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lung cancer
J&J’s Lung Cancer Combo Bests AstraZeneca’s Tagrisso, Reducing Risk of Death 25%
The latest data from Johnson and Johnson’s Rybrevant and Lazcluze lung cancer combo was better than standard of care Tagrisso on overall survival. But analysts say the next step is getting a subcutaneous formula approved.
March 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Small Cell Lung Cancer Market Size to Reach USD 23.0 Billion by 2035, Impelled by Improved Early Diagnosis & Biomarker Research
Small Cell Lung Cancer Market Outlook 2025-2035:
February 17, 2025
·
9 min read
Press Releases
Independent White Paper Highlights Real-World Impact of bioAffinity Technologies’ CyPath® Lung in Diagnosing Early-Stage Lung Cancer
May 8, 2025
·
5 min read
Press Releases
CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting
April 29, 2025
·
4 min read
Press Releases
Lung Cancer Therapeutics Market Size to Reach USD 71.30 Bn by 2034
February 26, 2025
·
1 min read
Press Releases
Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer
March 27, 2025
·
7 min read
Press Releases
BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™
April 24, 2025
·
5 min read
Press Releases
Paragonix Launches Initiative to Increase Donor Lung Utilization
April 24, 2025
·
4 min read
Press Releases
Dizal to Showcase Data in Hematologic Malignancies and Lung Cancer at ASCO 2025
April 24, 2025
·
7 min read
Press Releases
Lung Immune Cell Type “Quietly” Controls Inflammation in COVID-19
April 28, 2025
·
5 min read
1 of 29,479
Next
